<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vguit</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник Воронежского государственного университета инженерных технологий</journal-title><trans-title-group xml:lang="en"><trans-title>Proceedings of the Voronezh State University of Engineering Technologies</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-910X</issn><issn pub-type="epub">2310-1202</issn><publisher><publisher-name>VSUET</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20914/2310-1202-2026-2-</article-id><article-id custom-type="elpub" pub-id-type="custom">vguit-3823</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Пищевые системы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Food systems</subject></subj-group></article-categories><title-group><article-title>Критический анализ государственной промышленной политики в области биотехнологии в условиях деглобализации</article-title><trans-title-group xml:lang="en"><trans-title>Critical analysis of state industrial policy in the field of biotechnology in the context of deglobalization</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3553-741Х</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Решетникова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Reshetnikova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.э.н., доцент, кафедра корпоративных информационных систем и програм-мирования, пр-т Революции, 19, г. Воронеж, 394036, Россия</p></bio><bio xml:lang="en"><p>Dr. Sci. (Econ.), professor, Department of Corporate Information Systems and Programming, Revolution Av., 19 Voronezh, 394036, Russia</p></bio><email xlink:type="simple">fltvmrn@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9141-5580</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Серебрякова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Serebryakova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.э.н., профессор, кафедра экономики и финансов, ул. Тимирязева, 8, 394087, г. Воронеж, Россия</p></bio><bio xml:lang="en"><p>Dr. Sci. (Econ.), professor, Department of Economics and Finance, 394087, Voronezh, Timiryazevo St., 8, Russia</p></bio><email xlink:type="simple">nad.serebryakova@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3829-2972</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жахов</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhakhov</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.э.н., профессор, кафедра экономики, управления и аудита,</p></bio><bio xml:lang="en"><p>Dr. Sci. (Econ.), professor, Management, and Audit department, 50th Anniversary of October, Bldg. 94, Kursk, 305040, Russia.</p></bio><email xlink:type="simple">zhakhov@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7324-5338</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дзахмишева</surname><given-names>И. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzakhmisheva</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.э.н., профессор, Институт менеджмента, туризма и индустрии гостеприимства, ул. Чернышевского, 173, г. Нальчик, Российская Федерация, 360004</p></bio><bio xml:lang="en"><p>Dr. Sci. (Econ.), professor, Institute of Management, Tourism, and Hospitality Industry, Chernyshevsky Street, 173, Nalchik, Russian Federation, 360004</p></bio><email xlink:type="simple">irina_dz@list.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Воронежский государственный университет инженерных технологий</institution></aff><aff xml:lang="en"><institution>Voronezh State University of Engineering Technologies</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Воронежский лесотехнический университет им. Г.Ф. Морозова</institution></aff><aff xml:lang="en"><institution>Voronezh Forest Engineering University named after G.F. Morozov</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Юго-Западный государственный университет</institution></aff><aff xml:lang="en"><institution>Southwestern State University</institution></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Кабардино-Балкарский государственный университет им. Х.М. Бербекова</institution></aff><aff xml:lang="en"><institution>Kabardino-Balkarian State University named after Kh. M. Berbekov</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2026</year></pub-date><volume>88</volume><issue>2</issue><fpage>203</fpage><lpage>210</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Решетникова М.В., Серебрякова Н.А., Жахов Н.В., Дзахмишева И.Ш., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Решетникова М.В., Серебрякова Н.А., Жахов Н.В., Дзахмишева И.Ш.</copyright-holder><copyright-holder xml:lang="en">Reshetnikova M.V., Serebryakova N.A., Zhakhov N.V., Dzakhmisheva I.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vestnik-vsuet.ru/vguit/article/view/3823">https://www.vestnik-vsuet.ru/vguit/article/view/3823</self-uri><abstract><p>Биотехнология в последние два десятилетия превратилась в стратегическую отрасль, определяющую конкурентоспособность национальных экономик в сфере здравоохранения, сельского хозяйства, промышленности и экологии. Государственная промышленная политика в данной области традиционно строится на принципах стимулирования исследований, поддержки трансфера технологий, развития производственных мощностей и формирования кадрового потенциала. Однако в условиях нарастающей деглобализации, характеризующейся фрагментацией глобальных цепочек создания стоимости, усилением экспортного контроля, технологическим протекционизмом и пересмотром моделей международного сотрудничества, традиционные подходы к регулированию биотехнологической отрасли сталкиваются с системными ограничениями. Цель данной статьи состоит в критическом анализе современных инструментов государственной промышленной политики в сфере биотехнологий с учетом трансформационных вызовов деглобализации, выявлении их эффективности, противоречий и рисков, а также в формулировании обоснованных выводов для совершенствования стратегического управления отраслью. В исследовании применён комплексный методологический подход, сочетающий институциональный анализ, сравнительное изучение национальных стратегий и сценарное моделирование. Показано, что в новых геополитических и экономических условиях требуется переход от линейных моделей поддержки к адаптивным, гибким механизмам, ориентированным на укрепление технологического суверенитета, диверсификацию кооперационных связей, развитие устойчивых национальных инновационных экосистем и обеспечение биобезопасности. Сформулированы практические предложения по модернизации регуляторных инструментов, включая совершенствование нормативно-правовой базы, стимулирование частно-государственного партнёрства, развитие критических производственных компетенций и построение новых форм избирательного международного научно-технологического взаимодействия. Особое внимание уделено балансу между открытостью и защитой стратегических интересов, а также необходимости опережающего развития кадрового потенциала.</p></abstract><trans-abstract xml:lang="en"><p>Over the past two decades, biotechnology has emerged as a strategic sector, defining the competitiveness of national economies in healthcare, agriculture, manufacturing, and the environment. State industrial policy in this area has traditionally been based on the principles of stimulating research, supporting technology transfer, developing production capacity, and building human resources. However, in the context of increasing deglobalization, characterized by the fragmentation of global value chains, increased export controls, technological protectionism, and a revision of international cooperation models, traditional approaches to regulating the biotechnology industry are facing systemic limitations. The purpose of this article is to critically analyze current instruments of state industrial policy in the field of biotechnology, taking into account the transformative challenges of deglobalization. This article identifies their effectiveness, contradictions, and risks, and formulates substantiated conclusions for improving the strategic management of the industry. The study applies a comprehensive methodological approach combining institutional analysis, a comparative study of national strategies, and scenario modeling. It is shown that the new geopolitical and economic conditions require a transition from linear support models to adaptive, flexible mechanisms aimed at strengthening technological sovereignty, diversifying cooperative ties, developing sustainable national innovation ecosystems, and ensuring biosecurity. Practical proposals are formulated for modernizing regulatory instruments, including improving the legal framework, stimulating public-private partnerships, developing critical production competencies, and establishing new forms of selective international scientific and technological cooperation. Particular attention is paid to the balance between openness and the protection of strategic interests, as well as the need for accelerated development of human resources.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>промышленной политики в сфере биотехнологий</kwd><kwd>деглобализация трансформации биотехнологической политики биотехнологии</kwd><kwd>промышленная политика</kwd><kwd>деглобализация</kwd><kwd>технологический суверенитет</kwd><kwd>государственное регулирование</kwd><kwd>цепочки создания стоимости</kwd><kwd>инновационная экосистема</kwd><kwd>стратегическое управление</kwd><kwd>биобезопасность</kwd><kwd>трансфер технологий.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>industrial policy in the field of biotechnology</kwd><kwd>deglobalization of the transformation of biotechnology policy</kwd><kwd>industrial policy</kwd><kwd>deglobalization</kwd><kwd>technological sovereignty</kwd><kwd>state regulation</kwd><kwd>value chains</kwd><kwd>innovation ecosystem</kwd><kwd>strategic management</kwd><kwd>biosafety</kwd><kwd>technology transfer.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Baldwin R., Evenett S.J. Trade and Industrial Policy in the Age of Geoeconomics. CEPR/VoxEU, 2022. URL: https://voxeu.org (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Baldwin R., Evenett S.J. Trade and Industrial Policy in the Age of Geoeconomics. CEPR/VoxEU, 2022. Available at: https://voxeu.org (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">BIOSECURE Act: Public Law 119–60. U.S. Congress, signed December 18, 2025, as part of NDAA FY2026. URL: https://www.congress.gov (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">BIOSECURE Act: Public Law 119–60. U.S. Congress, signed December 18, 2025, as part of NDAA FY2026. Available at: https://www.congress.gov (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bureau of Industry and Security. Controls on Laboratory Equipment (RIN 0694-AJ95) // Federal Register. January 16, 2025. URL: https://www.federalregister.gov (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Bureau of Industry and Security. Controls on Laboratory Equipment (RIN 0694-AJ95). Federal Register. January 16, 2025. Available at: https://www.federalregister.gov (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">CSIS. Understanding the National Security Commission on Emerging Biotechnology Report. Washington: CSIS, 2025. URL: https://www.csis.org (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">CSIS. Understanding the National Security Commission on Emerging Biotechnology Report. Washington: CSIS, 2025. Available at: https://www.csis.org (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Duke University Health Policy. Building a Resilient and Secure Pharmaceutical Supply Chain. November 2024. URL: https://healthpolicy.duke.edu (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Duke University Health Policy. Building a Resilient and Secure Pharmaceutical Supply Chain. November 2024. Available at: https://healthpolicy.duke.edu (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">EC Joint Research Centre. The Global Landscape of Biotech Innovation: State of Play. March 2024. URL: https://joint-research-centre.ec.europa.eu (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">EC Joint Research Centre. The Global Landscape of Biotech Innovation: State of Play. March 2024. Available at: https://joint-research-centre.ec.europa.eu (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">EFPIA. A Comparative Analysis of Biopharmaceutical Strategies in 10 Countries. Brussels: EFPIA, 2025.</mixed-citation><mixed-citation xml:lang="en">EFPIA. A Comparative Analysis of Biopharmaceutical Strategies in 10 Countries. Brussels: EFPIA, 2025.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">European Commission. A new EU Bioeconomy Strategy for a sustainable Europe. Brussels, 2022; Updated Strategy, November 2025. URL: https://ec.europa.eu (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">European Commission. A new EU Bioeconomy Strategy for a sustainable Europe. Brussels, 2022; Updated Strategy, November 2025. Available at: https://ec.europa.eu (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">European Commission. Biotech Act – COM(2025) 1022 final. December 16, 2025. URL: https://eur-lex.europa.eu (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">European Commission. Biotech Act – COM(2025) 1022 final. December 16, 2025. Available at: https://eur-lex.europa.eu (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Government of India. BioE3 Policy. August 2024; India BioEconomy Report 2025. URL: https://www.india.gov.in (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Government of India. BioE3 Policy. August 2024; India BioEconomy Report 2025. Available at: https://www.india.gov.in (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Grand View Research. Biotechnology Market Size, Share &amp; Trends Analysis Report, 2024–2030. 2024. URL: https://www.grandviewresearch.com (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Grand View Research. Biotechnology Market Size, Share &amp; Trends Analysis Report, 2024–2030. 2024. Available at: https://www.grandviewresearch.com (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">IMF. The Price of De-Risking: Reshoring and Friend-shoring Scenarios // IMF Working Paper. 2024. № 122. URL: https://www.imf.org (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">IMF. The Price of De-Risking: Reshoring and Friend-shoring Scenarios. IMF Working Paper. 2024. no. 122. Available at: https://www.imf.org (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Innovation Ecosystems and Technology Policy in High-Risk Sectors // Research Policy. 2022–2024. V. 51–53.</mixed-citation><mixed-citation xml:lang="en">Innovation Ecosystems and Technology Policy in High-Risk Sectors. Research Policy. 2022–2024. vol. 51–53.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Interfax. Size of Biotechnology Market in Russia. March 2025. URL: https://www.interfax.ru (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Interfax. Size of Biotechnology Market in Russia. March 2025. Available at: https://www.interfax.ru (accessed: 20.04.2026) (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Japan Bioeconomy Strategy. METI, Keidanren. June 2024. URL: https://www.meti.go.jp (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Japan Bioeconomy Strategy. METI, Keidanren. June 2024. Available at: https://www.meti.go.jp (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Juhász R., Lane N., Rodrik D. The New Economics of Industrial Policy // Annual Review of Economics. 2024. V. 16. P. 213–242. doi: 10.1146/annurev-economics-081023-024638</mixed-citation><mixed-citation xml:lang="en">Juhász R., Lane N., Rodrik D. The New Economics of Industrial Policy. Annual Review of Economics. 2024. vol. 16. pp. 213–242. doi: 10.1146/annurev-economics-081023-024638.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Korea Ministry of Health. Bio Korea 2025 // National Bio Committee. January 2025. URL: https://www.mohw.go.kr (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Korea Ministry of Health. Bio Korea 2025. National Bio Committee. January 2025. Available at: https://www.mohw.go.kr (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mazzucato M. The Entrepreneurial State: Debunking Public vs. Private Sector Myths. London: Anthem Press, 2013.</mixed-citation><mixed-citation xml:lang="en">Mazzucato M. The Entrepreneurial State: Debunking Public vs. Private Sector Myths. London: Anthem Press, 2013.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mazzucato M. The Inclusive Entrepreneurial State // Oxford Open Economics. 2024. V. 3. URL: https://academic.oup.com/ooec (дата обращения: 20.04.2026). doi: 10.1093/ooec/odae010</mixed-citation><mixed-citation xml:lang="en">Mazzucato M. The Inclusive Entrepreneurial State. Oxford Open Economics. 2024. vol. 3. Available at: https://academic.oup.com/ooec (accessed: 20.04.2026). doi: 10.1093/ooec/odae010.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mazzucato M., Rodrik D. Industrial Policy with Conditionalities // UCL IIPP Working Paper. 2023. № 2023–07. URL: https://www.ucl.ac.uk/iipp (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Mazzucato M., Rodrik D. Industrial Policy with Conditionalities. UCL IIPP Working Paper. 2023. no. 2023–07. Available at: https://www.ucl.ac.uk/iipp (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">MERICS. Lab Leader, Market Ascender: China's Rise in Biotechnology. Berlin: MERICS, 2024.</mixed-citation><mixed-citation xml:lang="en">MERICS. Lab Leader, Market Ascender: China's Rise in Biotechnology. Berlin: MERICS, 2024.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">OECD. Science, Technology and Innovation Outlook 2025. Paris: OECD Publishing, 2025. doi: 10.1787/sti_outlook-2025-en</mixed-citation><mixed-citation xml:lang="en">OECD. Science, Technology and Innovation Outlook 2025. Paris: OECD Publishing, 2025. doi: 10.1787/sti_outlook-2025-en.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Policy and Funding Trends in Global Biotechnology // Nature Biotechnology. 2021–2025. URL: https://www.nature.com/nbt (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Policy and Funding Trends in Global Biotechnology. Nature Biotechnology. 2021–2025. Available at: https://www.nature.com/nbt (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Precedence Research. Biotechnology Market Size to Hit USD 6.34 Trillion by 2035. URL: https://www.precedenceresearch.com (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Precedence Research. Biotechnology Market Size to Hit USD 6.34 Trillion by 2035. Available at: https://www.precedenceresearch.com (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Stanford SETR. Biotechnology and Synthetic Biology Review. Stanford: Stanford Engineering Technology Review, 2025. URL: https://setr.stanford.edu (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Stanford SETR. Biotechnology and Synthetic Biology Review. Stanford: Stanford Engineering Technology Review, 2025. Available at: https://setr.stanford.edu (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">The White House. Executive Order 14081 on Advancing Biotechnology and Biomanufacturing Innovation. September 2022. URL: https://www.whitehouse.gov (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">The White House. Executive Order 14081 on Advancing Biotechnology and Biomanufacturing Innovation. September 2022. Available at: https://www.whitehouse.gov (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">UNCTAD. Trade and Development Report 2025: Fragmentation and Geopolitical Tensions. Geneva: United Nations, 2025.</mixed-citation><mixed-citation xml:lang="en">UNCTAD. Trade and Development Report 2025: Fragmentation and Geopolitical Tensions. Geneva: United Nations, 2025.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">WIPO. World Intellectual Property Indicators 2025: Highlights – Patents. Geneva: WIPO, 2025.</mixed-citation><mixed-citation xml:lang="en">WIPO. World Intellectual Property Indicators 2025: Highlights – Patents. Geneva: WIPO, 2025.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">World Bank. Biotechnology for Sustainable Development. Washington, DC: World Bank, 2021.</mixed-citation><mixed-citation xml:lang="en">World Bank. Biotechnology for Sustainable Development. Washington, DC: World Bank, 2021.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">WTO. Global Value Chains Development Report 2025. Geneva: WTO, 2025.</mixed-citation><mixed-citation xml:lang="en">WTO. Global Value Chains Development Report 2025. Geneva: WTO, 2025.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Национальный проект «Технологическое обеспечение биоэкономики»: утв. в декабре 2024 г. М., 2024.</mixed-citation><mixed-citation xml:lang="en">National Project "Technological Support for Bioeconomy": approved in December 2024. Moscow, 2024. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">О развитии фармацевтической и медицинской промышленности в Российской Федерации: Государственная программа РФ на период до 2030 года / Минпромторг России. М., 2021.</mixed-citation><mixed-citation xml:lang="en">On the Development of the Pharmaceutical and Medical Industry in the Russian Federation: State Program of the Russian Federation for the Period up to 2030. Ministry of Industry and Trade of Russia. Moscow, 2021. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Об утверждении Стратегии развития биоэкономики в Российской Федерации на период до 2030 года: Распоряжение Правительства РФ от 12.08.2020 № 2072-р // Собрание законодательства Российской Федерации. 2020. № 34. Ст. 5612.</mixed-citation><mixed-citation xml:lang="en">On Approval of the Strategy for the Development of Bioeconomy in the Russian Federation for the Period up to 2030: Decree of the Government of the Russian Federation No. 2072-r of August 12, 2020. Collection of Legislation of the Russian Federation. 2020. no. 34. art. 5612. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Проекты в сфере биотехнологий. URL: https://poiskinvestorov.ru/projects-biotechnology-projects (дата обращения: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">Projects in the field of biotechnology. Available at: https://poiskinvestorov.ru/projects-biotechnology-projects (accessed: 20.04.2026) (in Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
